Robeco Institutional Asset Management B.V. Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Robeco Institutional Asset Management B.V. increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 711,450 shares of the healthcare conglomerate's stock after buying an additional 1,265 shares during the quarter. UnitedHealth Group comprises approximately 0.7% of Robeco Institutional Asset Management B.V.'s investment portfolio, making the stock its 24th largest holding. Robeco Institutional Asset Management B.V. owned 0.08% of UnitedHealth Group worth $372,622,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Up 2.1%

Shares of NYSE UNH traded up $6.23 during trading on Friday, hitting $308.85. 13,584,804 shares of the company were exchanged, compared to its average volume of 7,465,895. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The company has a fifty day moving average price of $339.15 and a 200-day moving average price of $456.28. The firm has a market capitalization of $280.17 billion, a PE ratio of 12.93, a P/E/G ratio of 1.43 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the previous year, the business posted $6.91 earnings per share. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on UNH shares. Barclays dropped their price objective on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. Morgan Stanley decreased their target price on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Wells Fargo & Company reiterated an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Finally, Oppenheimer decreased their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the company's stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of the company's stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock valued at $31,607,768 in the last three months. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.